Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Surprise! Saturn's huge moon Titan may not have a buried ocean after all - 2Congolese rape survivors search in vain for medicine after USAID cuts
- 3The Best Computer games for Multiplayer Fun
- 4Parents search for children missing since a volcanic eruption in Colombia 40 years ago
- 5Flying without a Real ID? That'll soon cost you $45, TSA says.
- Revealing the Specialty of Food Matching: Improving Culinary Encounters
- I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
- No respite for German economy as experts slash forecast over Iran war
- 'Fertiliser costs mean I'm better off not planting'
- A Past filled with Old Civilizations: The World's Most established Societies
- ‘Aid for Ukraine’ pierogi fundraiser event
- The Meaning of Breaking the Pen's Nib in Death penalties
- Famous Restroom Beautifying Styles For 2024
- Turkey, Egypt, Qatar discuss second phase of Gaza ceasefire deal
